李菲菲, 黄钰钦, 陈若霞, 叶冰冰, 苏丹艳, 庞玉生. 肺动脉高压相关线粒体自噬生物标志物及其作用的分析与验证[J]. 广西医科大学学报, 2024, 41(3): 419-429. DOI: 10.16190/j.cnki.45-1211/r.2024.03.014
引用本文: 李菲菲, 黄钰钦, 陈若霞, 叶冰冰, 苏丹艳, 庞玉生. 肺动脉高压相关线粒体自噬生物标志物及其作用的分析与验证[J]. 广西医科大学学报, 2024, 41(3): 419-429. DOI: 10.16190/j.cnki.45-1211/r.2024.03.014
LI Feifei, HUANG Yuqin, CHEN Ruoxia, YE Bingbing, SU Danyan, PANG Yusheng. Analysis and validation of mitochondrial autophagy biomarkers associated with pulmonary arterial hypertension[J]. Journal of Guangxi Medical University, 2024, 41(3): 419-429. DOI: 10.16190/j.cnki.45-1211/r.2024.03.014
Citation: LI Feifei, HUANG Yuqin, CHEN Ruoxia, YE Bingbing, SU Danyan, PANG Yusheng. Analysis and validation of mitochondrial autophagy biomarkers associated with pulmonary arterial hypertension[J]. Journal of Guangxi Medical University, 2024, 41(3): 419-429. DOI: 10.16190/j.cnki.45-1211/r.2024.03.014

肺动脉高压相关线粒体自噬生物标志物及其作用的分析与验证

Analysis and validation of mitochondrial autophagy biomarkers associated with pulmonary arterial hypertension

  • 摘要: 目的:通过生物信息学方法筛选肺动脉高压(PAH)相关线粒体自噬差异表达基因,为进一步研究线粒体自噬提供新依据。方法:从高通量基因表达数据库(GEO)下载PAH相关数据集,分为测试集和验证集,从分子签名数据库(MSigDB)和通路统一数据库下载线粒体自噬相关基因,筛选线粒体自噬相关的PAH差异表达基因并进行基因本体论(GO)注释分析、京都基因和基因组百科全书(KEGG)通路富集分析、蛋白质-蛋白质互作分析等。通过验证集验证生物标记物,将具有显著性差异且差异趋势一致的关键基因进行ROC验证,并收集先天性心脏病(CHD)相关PAH(PAH-CHD)及CHD共32例患儿外周血进行关键基因实时荧光定量聚合酶链反应(RT-qPCR)表达验证。结果:收集到数据集GSE113439、GSE15197、GSE117261作为测试集,GSE38267作为验证集,共得到11个PAH相关线粒体自噬差异表达基因,这些基因主要富集在线粒体自噬-动物、神经退行性疾病-多种疾病通路、自噬-动物、志贺氏菌病、粘附连接、胞吞、帕金森病等通路中,其中5个关键基因(GABARAPL2, OPTN, RNF41, SRC, UBB)在合并数据集和验证集PAH组和正常组(Normal组)存在显著性差异且差异趋势一致。GABARAPL2, OPTN, UBB mRNA在PAH-CHD外周血的表达与预测趋势一致,而GABARAPL2 mRNA在PAH-CHD组外周血中表达显著升高(P<0.05)。结论:GABARAPL2可能在PAH相关线粒体自噬中起调控作用,具体的机制仍需要进一步的体内和体外验证。

     

    Abstract: Objective:To screen the differentially expressed genes of mitochondrial autophagy associated with pulmonary arterial hypertension (PAH) by bioinformatics, and to provide a new basis for further study of mitochondrial autophagy. Methods:The PAH related dataset was downloaded from the Gene Expression Omnibus (GEO), and was divided into test and validation sets. Mitochondrial autophagy related genes were downloaded from the Molecular Signatures Database (MSigDB) and pathway unified database. The differentially expressed genes associated with mitochondrial autophagy in PAH were screened and analyzed for Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and protein-protein interaction, etc. The biomarkers were verified by validation set, and hub genes with significant differences and consistent differences were validated by receiver operating characteristic (ROC) curve. Peripheral blood of 32 children with congenital heart disease (CHD)-associated PAH (PAH-CHD) and CHD were collected for reverse transcription-quantitative polymerase chain reaction (RT-qPCR) expression verification of hub genes. Results:The data sets GSE113439, GSE15197, GSE117261 were collected as the test set, and GSE38267 as the verification set. A total of 11 differentially expressed genes of mitochondrial autophagy associated with PAH were obtained. These genes were mainly concentrated in mitophagy-animal, pathways of neurodegeneration-multiple diseases, autophagy- animal, Shigellosis, adherens junction, endocytosis, Parkinson's disease, etc. Among them, five hub genes (GABARAPL2, OPTN, RNF41, SRC, UBB) showed significant differences between PAH and normal groups in the combined data set and validation set, and the difference trend was consistent. The mRNA expression of GABARAPL2, OPTN and UBB in the peripheral blood of PAH-CHD group was consistent with the predicted trend, while the mRNA expression of GABARAPL2 in the peripheral blood of PAH-CHD group was significantly increased (P<0.05). Conclusion:GABARAPL2 may play a regulatory role in mitochondrial autophagy associated with PAH. The specific mechanism still needs to be further verified in vivo and in vitro.

     

/

返回文章
返回